59 related articles for article (PubMed ID: 26239805)
1. Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cells.
Pfankuchen DB; Stölting DP; Schlesinger M; Royer HD; Bendas G
Biochem Pharmacol; 2015 Sep; 97(2):147-57. PubMed ID: 26239805
[TBL] [Abstract][Full Text] [Related]
2. Enzyme-Instructed Intracellular Molecular Self-Assembly to Boost Activity of Cisplatin against Drug-Resistant Ovarian Cancer Cells.
Li J; Kuang Y; Shi J; Zhou J; Medina JE; Zhou R; Yuan D; Yang C; Wang H; Yang Z; Liu J; Dinulescu DM; Xu B
Angew Chem Int Ed Engl; 2015 Nov; 54(45):13307-11. PubMed ID: 26365295
[TBL] [Abstract][Full Text] [Related]
3. Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration.
Fu L; Zhang F; Li G; Onishi A; Bhaskar U; Sun P; Linhardt RJ
J Pharm Sci; 2014 May; 103(5):1375-83. PubMed ID: 24634007
[TBL] [Abstract][Full Text] [Related]
4. Endothelial barrier protective properties of low molecular weight heparin: A novel potential tool in the prevention of cancer metastasis?
Kevane B; Egan K; Allen S; Maguire P; Neary E; Lennon Á; Ní Áinle F
Res Pract Thromb Haemost; 2017 Jul; 1(1):23-32. PubMed ID: 30046671
[TBL] [Abstract][Full Text] [Related]
5. Spontaneous gall bladder haemorrhage in a renal dialysis patient following haemodialysis with tinzaparin.
Borman N; Graetz K
NDT Plus; 2010 Aug; 3(4):376-8. PubMed ID: 25949435
[TBL] [Abstract][Full Text] [Related]
6. The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor Models.
Mueller T; Pfankuchen DB; Wantoch von Rekowski K; Schlesinger M; Reipsch F; Bendas G
Molecules; 2017 May; 22(5):. PubMed ID: 28467373
[TBL] [Abstract][Full Text] [Related]
7. Start me up! Recurrent ventricular tachydysrhythmias following intentional concentrated caffeine ingestion.
Laskowski LK; Henesch JA; Nelson LS; Hoffman RS; Smith SW
Clin Toxicol (Phila); 2015; 53(8):830-3. PubMed ID: 26279469
[TBL] [Abstract][Full Text] [Related]
8. The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids.
Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L
Int J Clin Pract; 2015 Nov; 69(11):1366-76. PubMed ID: 26268890
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Antitumour Activity of Polysaccharides.
Jin H; Li M; Tian F; Yu F; Zhao W
Molecules; 2022 Nov; 27(22):. PubMed ID: 36432183
[TBL] [Abstract][Full Text] [Related]
10. Not Just Anticoagulation-New and Old Applications of Heparin.
Zang L; Zhu H; Wang K; Liu Y; Yu F; Zhao W
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296562
[TBL] [Abstract][Full Text] [Related]
11. Tinzaparin-a review of its molecular profile, pharmacology, special properties, and clinical uses.
Amerali M; Politou M
Eur J Clin Pharmacol; 2022 Oct; 78(10):1555-1565. PubMed ID: 35871241
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma.
Tamura R; Yoshihara K; Enomoto T
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565252
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulation for atrial fibrillation in active cancer.
Farmakis D; Papakotoulas P; Angelopoulou E; Bischiniotis T; Giannakoulas G; Kliridis P; Richter D; Paraskevaidis I
Oncol Lett; 2022 Apr; 23(4):124. PubMed ID: 35261638
[TBL] [Abstract][Full Text] [Related]
14. Tinzaparin inhibits VL30 retrotransposition induced by oxidative stress and/or VEGF in HC11 mouse progenitor mammary cells: Association between inhibition of cancer stem cell proliferation and mammosphere disaggregation.
Mantziou S; Markopoulos G; Thrasyvoulou S; Noutsopoulos D; Gkartziou F; Vartholomatos G; Tzavaras T
Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34558648
[TBL] [Abstract][Full Text] [Related]
15.
Camacho-Alonso F; Gómez-Albentosa T; Oñate-Sánchez RE; Tudela-Mulero MR; Sánchez-Siles M; Gómez-García FJ; Guerrero-Sánchez Y
Front Oncol; 2020; 10():549412. PubMed ID: 33312942
[TBL] [Abstract][Full Text] [Related]
16. Selectins: An Important Family of Glycan-Binding Cell Adhesion Molecules in Ovarian Cancer.
Hassan AA; Artemenko M; Tang MKS; Wong AST
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32785160
[TBL] [Abstract][Full Text] [Related]
17. Pleiotropic Effects of Heparins: From Clinical Applications to Molecular Mechanisms in Hepatocellular Carcinoma.
Korhan P; Yılmaz Y; Bağırsakçı E; Güneş A; Topel H; Carr BI; Atabey N
Can J Gastroenterol Hepatol; 2018; 2018():7568742. PubMed ID: 30425976
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.
Samuel P; Mulcahy LA; Furlong F; McCarthy HO; Brooks SA; Fabbri M; Pink RC; Carter DRF
Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1737):. PubMed ID: 29158318
[TBL] [Abstract][Full Text] [Related]
19. Association between B7-H1 and cervical cancer: B7-H1 impairs the immune response in human cervical cancer cells.
Tao J; Dai J; Hou S
Exp Ther Med; 2017 Nov; 14(5):4125-4133. PubMed ID: 29104629
[TBL] [Abstract][Full Text] [Related]
20. The Role of Tinzaparin in Oncology.
Dimakakos EP; Vathiotis I; Syrigos K
Clin Appl Thromb Hemost; 2018 Jul; 24(5):697-707. PubMed ID: 29088922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
